Bayo, Von Jayson C.

HRN: 29-32-89  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/30/2026
08/06/2026
IV
35mg
Q24
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: